Appointment of Adam Martin

August 22, 2022

PremaLabs Diagnostics is pleased to announce the appointment of Adam Martin to the role of Chief Commercial Officer.

Adam is an experienced commercial leader with over 20 years’ experience working globally across start up and market leading companies within Diagnostics, Pharmaceuticals, Medical Device, and SaaS companies most notably MSD, Abbott, LivaNova and Coloplast. He has built numerous sales and marketing teams and his strategic acumen combined with creative marketing enables him to devise and implement plans which drive revenue and enable companies to make a difference to the patients and physicians they serve. Passionate about the world of point of care testing since his time at Abbott, Adam has built a strong network of contacts and advocates globally with the aim of making point of care accessible to all patients who deserve and require immediate test results.

On his appointment, Adam said: “The reason I’ve joined PremaLabs Diagnostics is because of the founders, our products and the opportunity to build a global team. Point of care testing is still not fully utilised in many countries, and with so many people unable to access appropriate treatment, at the time they need it, means this technology can make a huge difference to patient lives, enhancing treatment pathways. Disrupting healthcare is what we aim to do and when I walked into the office on day 1, I instantly saw our wider team are all engaged and committed to the journey ahead. We have great people here and are aiming to add more like-minded people as we expand and achieve our goals.”


Contact us